×
Site Menu
Everything
International
Politics
Local
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
5 months ago
58
Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.
Read Entire Article
Homepage
Science
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Related
Yellowstone’s Wolves: A Debate Over Their Role in the Park’s...
1 week ago
40
Lori and George Schappell, Long-Surviving Conjoined Twins, D...
1 week ago
22
Like Moths to a Flame? We May Need a New Phrase.
1 week ago
15
Lyrid Meteor Shower 2024: Peak Time and How to Watch
1 week ago
14
Trending
1.
Marijuana
2.
Mike Johnson
3.
AMD stock
4.
UCLA
5.
Brian McCardie
6.
May Day
7.
Knicks
8.
Joel Embiid
9.
Boston Bruins
10.
Knicks vs 76ers
Popular
So You Wanna Talk About the Best CBD Brands? Our 7 Picks and...
9 months ago
813
Sennheiser Momentum True Wireless 4 Review: Decent Sound but...
1 month ago
690
What do tickets cost to see the ‘How Did This Get Made’ podc...
8 months ago
689
Inside the Golden Globes 2024 afterparties: See how celebrit...
3 months ago
601
Travel Behind the Scenes of Star Wars Outlaws
9 months ago
473